Clinical characteristics and surgical management of facial infiltrating lipomatosis: a single center experience.

"Declarations Ethics approval and consent to participateThe study was approved by the Ethics Board of Shanghai Ninth Hospital, Shanghai Jiaotong University of Medicine (SH9H-2023-T329-1). Written informed consent forms were signed by patients whose photographs were presented in this study. Consent for publicationThe consent for publication was acquired from patients or patients’ parents. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This research was supported by the Major and Key Cultivation Projects of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine (No. JYZP005), Treatment and mechanism of PI3K/mTOR dual-target inhibitor (WX390) on PIK3CA-related overgrowth spectrum (PROS) (No. JYWO22075), Shanghai Sailing Program (No.22YF1421900), and Rare Disease Registration Platform of Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine (No. JYHJB02)."

"Funding: This research was supported by the Major and Key Cultivation Projects of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine (No. JYZP005), Treatment and mechanism of PI3K/mTOR dual-target inhibitor (WX390) on PIK3CA-related overgrowth spectrum (PROS) (No. JYWO22075), Shanghai Sailing Program (No.22YF1421900), and Rare Disease Registration Platform of Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine (No. JYHJB02)."